美国药品NDC(国家药品编码)与药品说明书数据库(U.S. FDA National Drug Code DataBase)
检索条件:" 注册申请号=ANDA077493"
NDC包装代码 产品NDC 产品类型 商品名 通用名 剂型 给药途径 上市日期 结束日期 市场类别 申请号 标签持有者 活性成分 规格 包装描述
70518-3941-0 70518-3941 HUMAN PRESCRIPTION DRUG Risperidone Risperidone TABLET ORAL 20231208 N/A ANDA ANDA077493 REMEDYREPACK INC. RISPERIDONE .5 mg/1 30 TABLET in 1 BLISTER PACK (70518-3941-0)
70518-3992-0 70518-3992 HUMAN PRESCRIPTION DRUG Risperidone Risperidone TABLET ORAL 20240123 N/A ANDA ANDA077493 REMEDYREPACK INC. RISPERIDONE 2 mg/1 30 TABLET in 1 BLISTER PACK (70518-3992-0)
70518-3883-0 70518-3883 HUMAN PRESCRIPTION DRUG Risperidone Risperidone TABLET ORAL 20230928 N/A ANDA ANDA077493 REMEDYREPACK INC. RISPERIDONE 1 mg/1 30 TABLET in 1 BLISTER PACK (70518-3883-0)
70518-3883-1 70518-3883 HUMAN PRESCRIPTION DRUG Risperidone Risperidone TABLET ORAL 20230928 N/A ANDA ANDA077493 REMEDYREPACK INC. RISPERIDONE 1 mg/1 60 TABLET in 1 BLISTER PACK (70518-3883-1)
0615-8288-39 0615-8288 HUMAN PRESCRIPTION DRUG Risperidone Risperidone TABLET ORAL 20190605 N/A ANDA ANDA077493 NCS HealthCare of KY, LLC dba Vangard Labs RISPERIDONE 2 mg/1 30 TABLET in 1 BLISTER PACK (0615-8288-39)
71610-259-30 71610-259 HUMAN PRESCRIPTION DRUG Risperidone Risperidone TABLET ORAL 20190403 N/A ANDA ANDA077493 Aphena Pharma Solutions - Tennessee, LLC RISPERIDONE 2 mg/1 30 TABLET in 1 BOTTLE (71610-259-30)
71610-259-45 71610-259 HUMAN PRESCRIPTION DRUG Risperidone Risperidone TABLET ORAL 20190403 N/A ANDA ANDA077493 Aphena Pharma Solutions - Tennessee, LLC RISPERIDONE 2 mg/1 45 TABLET in 1 BOTTLE (71610-259-45)
71610-259-15 71610-259 HUMAN PRESCRIPTION DRUG Risperidone Risperidone TABLET ORAL 20190403 N/A ANDA ANDA077493 Aphena Pharma Solutions - Tennessee, LLC RISPERIDONE 2 mg/1 15 TABLET in 1 BOTTLE (71610-259-15)
商品名称,通用名称,活性成分名称,申请号搜索 高级检索
©2006-2024 Drugfuture->U.S. FDA National Drug Code DataBase